Startups
e9 Treatments is a service provider and supplier of nanotechnology-based surface treatments designed to increase surface repellency and to help reduce buildup and fouling on metal surfaces.
e9 Treatments is working to support a cleaner world by providing simple, safe solutions that extend product performance and lifespan. Our products help to support environmental safety and sustainability through the elimination or reduction in the need for harsh cleaning chemicals and frequent maintenance.
[The use of this technology on devices used in the oil and gas industry and hydrocarbon environments is patent protected by e9 Treatments, Inc. www.e9treatments.com/patents]
e9 Treatments is working to support a cleaner world by providing simple, safe solutions that extend product performance and lifespan. Our products help to support environmental safety and sustainability through the elimination or reduction in the need for harsh cleaning chemicals and frequent maintenance.
[The use of this technology on devices used in the oil and gas industry and hydrocarbon environments is patent protected by e9 Treatments, Inc. www.e9treatments.com/patents]
Overview
Location
United States, Texas, Boerne
Employees
11-50
Founded date
2016
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 24, 2024 | SiteOne Therapeutics: A New Dawn in Non-Opioid Pain Management | In a world where pain management often leads to addiction, SiteOne Therapeutics is carving a new path. The San Francisco-based biotech has just secured $100 million in Series C funding, led by Novo Holdings. This investment marks a signific... |
| Dec 18, 2024 | Novo Holdings leads SiteOne's $100M series C for non-opioid pain treatments | SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral nervous system instead of the central nervous system. The biotech’s series C financing was led by Novo... |
| Jan 31, 2024 | Mental Health Startup Combining Psychiatry with Novel Treatments Launches with $5.4M in Funding | As a private practitioner, Cornell-trained psychiatrist Dr. Allie Sharma constantly found herself referring people to outside services, including for sleep, acupuncture and lifestyle issues. That’s why she co-founded Being Health, a startup... |
| Oct 9, 2023 | - | Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease |
| May 1, 2023 | Chemical Surface Treatment Market Is Expected to Grasp the Value of USD 18.95 Billion with Growing CAGR of 5.2% by 2032 | Reports And Data The global chemical surface treatment market size was USD 12.01 Billion in 2022 and is expected to reach USD 18.95 Billion in 2032 NEW YORK CITY, NEW YORK, USA, May 1, 2023 /EINPresswire.com/ -- Market Overview The global c... |
| Apr 26, 2023 | San Diego-based biotech startup Adcentrx Treatments raises USD 38 million in Series A+ funding | April 24, 2023, in Shanghai and San Diego – The biotechnology startup Adcentrx Treatments (“Adcentrx”) announces the completion of a USD 38 million Series A+ fundraising. Adcentrx is committed to revolutionizing Antibody-Drug Conjugate (ADC... |
| Oct 17, 2022 | Oncology Market to Surpass Valuation of $533.87 Billion by 2028 | Cost Pressures, Access Issues, and Resistance to New Treatments to Remain Key Challenges | Westford,USA, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Market is experiencing a period of rapid growth due to the increasing incidence of cancer worldwide. The latest estimates suggest that there will be 22 million new cancer cases an... |
| Aug 17, 2022 | EIB backs Polish biotech company Ryvu Therapeutics with €22M to develop new cancer treatments | Krakow, Poland-based Ryvu Therapeutics, a biopharmaceutical company that develops small molecule therapies to address clinical limitations of current oncology treatments, announced on Wednesday that it has received €22M from The European In... |
| Aug 17, 2022 | EIB backs Polish biotech Ryvu with €22 million to speed up discovery of new cancer treatments | As the world suffers from an unprecedented level of health crisis caused by the pandemic, addressing clinical limitations of current treatments and providing patients with access to innovative therapies has never been more critical. Polish ... |
Show more
Reviews 0
FAQ about e9 Treatments
When was e9 Treatments founded?
e9 Treatments was founded in 2016.
What has the press written about e9 Treatments?
Parsers VC has collected 12 articles mentioning e9 Treatments, among them “SiteOne Therapeutics: A New Dawn in Non-Opioid Pain Management” (Dec 24, 2024) and “Novo Holdings leads SiteOne's $100M series C for non-opioid pain treatments” (Dec 18, 2024).
Is e9 Treatments still active?
Yes, e9 Treatments is active; its latest activity on Parsers VC dates from Sep 8, 2026.